- Home
- MAGN vs AMLX Comparison
MAGN vs AMLX Comparison
Compare MAGN & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAGN
- AMLX
- Stock Information
- Founded
- MAGN 1864
- AMLX 2014
- Country
- MAGN United States
- AMLX United States
- Employees
- MAGN N/A
- AMLX N/A
- Industry
- MAGN Paper
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- MAGN Basic Materials
- AMLX Health Care
- Exchange
- MAGN Nasdaq
- AMLX Nasdaq
- Market Cap
- MAGN 455.0M
- AMLX 459.1M
- IPO Year
- MAGN N/A
- AMLX 2022
- Fundamental
- Price
- MAGN $12.45
- AMLX $5.05
- Analyst Decision
- MAGN Hold
- AMLX Buy
- Analyst Count
- MAGN 1
- AMLX 6
- Target Price
- MAGN $16.00
- AMLX $10.17
- AVG Volume (30 Days)
- MAGN 745.4K
- AMLX 911.0K
- Earning Date
- MAGN 08-15-2025
- AMLX 08-07-2025
- Dividend Yield
- MAGN N/A
- AMLX N/A
- EPS Growth
- MAGN N/A
- AMLX N/A
- EPS
- MAGN N/A
- AMLX N/A
- Revenue
- MAGN $2,636,000,000.00
- AMLX N/A
- Revenue This Year
- MAGN $47.87
- AMLX N/A
- Revenue Next Year
- MAGN $4.76
- AMLX N/A
- P/E Ratio
- MAGN N/A
- AMLX N/A
- Revenue Growth
- MAGN 15.87
- AMLX N/A
- 52 Week Low
- MAGN $11.43
- AMLX $1.62
- 52 Week High
- MAGN $26.78
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- MAGN N/A
- AMLX 48.04
- Support Level
- MAGN N/A
- AMLX $5.24
- Resistance Level
- MAGN N/A
- AMLX $5.66
- Average True Range (ATR)
- MAGN 0.00
- AMLX 0.34
- MACD
- MAGN 0.00
- AMLX -0.05
- Stochastic Oscillator
- MAGN 0.00
- AMLX 21.97
About MAGN Magnera Corporation Common Stock
Magnera Corp formerly Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company's reportable segments are; Composite Fibers, Spunlace. and Airlaid Materials. The Airlaid Materials segment which is also its key revenue generating segment, is a supplier of cellulose-based airlaid nonwoven materials used to manufacture consumer products for end-user markets. The Airlaid Materials segment produces materials used in feminine hygiene, specialty wipes, tabletop, home care, and other consumables. Geographically, the company derives majority of its revenue from Americas and rest from Europe, Middle East, Africa and Asia Pacific markets.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.